Smart ECM
Account
RESEubea SrlEvento 487945 / Edizione 1

Innovation in pneumology 5.0

Congresso RES internazionale di due giorni in pneumologia, rivolto a medici specialisti. Tratta BPCO, asma, cancro del polmone in medicina di precisione, malattie interstiziali, insufficienza respiratoria e ricerca traslazionale. Napoli, 29-30 ottobre 2026.

Provider
Eubea SrlEubea Srl (360)
Crediti ECM
4,5
Costo
Gratuito
Durata
15 ore
Date
29 - 30 ottobre 2026
Richiedi info iscrizione
Aggiungi al Piano

Razionale scientifico

The scientific program is intended to represent, for all participants, an update on the latest developments in physio-pathological, clinical, diagnostic, therapeutic and management aspects of respiratory diseases, as well as an opportunity to share views and knowledge for respiratory physicians and scientists who deal with acute or chronic respiratory pathologies. The main objective of the Conference is to create an interactive environment between speakers and attendees. Leading experts and academics in the field will participate, reporting not only on the theoretical aspects and scientific updates on their area of expertise, but also on their experience in practical management, ensuring a valuable learning experience. The congress will focus, among other topics, on: • Advances in COPD: from pathophysiology to therapeutic approaches • Innovation in diagnosis and therapy of lung cancer in the era of precision medicine • New directions on perioperative approach to Lung cancer • Interstitial lung diseases: from diagnosis to end stage lung • New frontiers in pharmacology of bronchial asthma • Management of acute and chronic respiratory failure • Advances in biomolecular knowledge in lung disorders

Luogo

Università degli Studi di Napoli Parthenope
Via Petrarca 80, Napoli (NA)

Programma

29 ottobre 2026· Università degli Studi di Napoli Parthenope, Via Petrarca 80, Napoli
  • 08:00–08:30Registration
  • 08:30–09:00Opening SessionA. Bianco
  • 09:00–09:20Syndromic framework of pulmonary fibrosisF. Perrotta
  • 09:20–09:40Physiopathology of connective and Interstitial Lung DiseasesF. Ciccia
  • 09:40–10:00Nerandomilast and beyond the novel weapons in the treatment of ILDsF. Luppi
  • 10:00–10:40Thoracic imaging of Pulmonary Fibrosis in the era of AIM.A. Mazzei
  • 10:40–11:00IntroductionF. Salvatore
  • 11:00–11:20Laboratory contribution to personalized medicineG. Castaldo
  • 11:20–11:40Genetic and Epigenetic Implications in Human CancerL. Altucci
  • 11:40–12:00Impacts of Microplastic and Nanoplastic on health status: A new disease Risk factorR. Marfella
  • 12:00–12:20COPD and Cardio-metabolic comorbidities?C. Ferri
  • 12:20–12:40ACBP/DBI as a Bench-to-Clinic Translational BiomarkerM.C. Maiuri
  • 12:40–13:30Welcome from the Authorities
  • 13:30–14:30Light Lunch
  • 14:30–14:50Early COPD and Predictors for disease progressionN. Scichilone
  • 14:50–15:10Cardiopulmonary prevention in COPD: The Impact of Inhaler TherapyC. Micheletto
  • 15:10–15:30Redefining Management Targets in COPDF. Braido
  • 15:30–15:50Ensifentrine: Bridging Pharmacology and Clinical Innovation in COPDP. Rogliani
  • 15:50–16:10GOLD Recommendations 2026A. Spanevello
  • 16:10–16:30Lecture "Home Non-Invasive Ventilation for COPD: who, why, how and where?"N. Hart
  • 16:30–16:40IntroductionG. Marone
  • 16:40–17:00Inhaled asthma therapy: from step-up to optimal controlE. Carpagnano
  • 17:00–17:20The era of biologics in asthmaG. Varricchi
30 ottobre 2026· Università degli Studi di Napoli Parthenope, Via Petrarca 80, Napoli
  • 08:00–08:30IntroductionA. Bianco, G. Mazzarella
  • 08:30–08:50Endobronchial strategies for malignant central airway obstructionG. Galluccio
  • 08:50–09:10Percutaneous interventional Radiology ProceduresG. Carrafiello
  • 09:10–09:30Evolutions of bronchoscopic tecniquesL. Zuccatosta
  • 09:30–09:50Lung cancer therapeutics via bronchoscopyN. Navani
  • Coffee Station
  • 09:50–10:10Mutational status assessment in Lung CancerG. Troncone
  • 10:10–10:30Lecture "The cell of origin of squamous cell cancer of the lung."S. Janes
  • 10:30–10:50Therapy of SCLC: Where we areE. Capelletto
  • 10:50–11:10Immunotherapy of advanced in NSCLCC. Della Corte
  • 11:10–11:30Targeted therapy: Where we are?D. Rocco
  • 11:30–11:50Metabolic reshaping of gut microbiome to enhance lung cancer therapyL. Pastore
  • 11:50–12:10Expert OpinionG. Stella, F. Zito Marino
  • 12:10–12:30EBUS and Lung Cancer StagingR. Trisolini
  • 12:30–12:50Perioperative immune check point inhibitors in Lung cancerF. Morgillo
  • 12:50–13:10Robotic surgery for lung CancerA. Fiorelli
  • 13:10–13:30Expert OpinionR. Pagliaro, F.S. Cerqua, F. Vitiello, G. Viscardi
  • 13:30–14:30Light lunch
  • 14:30–14:50Update on non-invasive ventilationS. Nava
  • 14:50–15:10HFNC vs NIVR. Scala
  • 15:10–15:30Inpatient vs outpatient setup for home non invasive ventilationP. Murphy
  • 15:30–15:50Pathophysiology of Small Airway Disfunction in Chronic Respiratory DiseasesD. Radovanovic
  • 15:50–16:10Expert OpinionC. Iadevaia, R. Pagliaro
  • 16:10–16:30RCT in lung diseases: the hospital pharmacistsA. Cristinziano
  • 16:30–16:50Approved and novel biologics in COPDA. Bianco, A. Schiattarella
  • 16:50–17:10Fatty acid Dysregulation: A metabolic Signature and potential Biomarker of Pulmonary diseaseF. Scialò
  • 17:10–17:20Adiponectin in Epithelial-Mesenchymal Transition and Lung cancer progressionE. Nigro
  • 17:20–17:30Lung cancer and COPDR. Pagliaro
  • 17:30–17:40Innovating the practical approach to NIV adaptation: follow the curvesL. Aronne
  • 17:40–17:50MRGE and RLF in respiratory diseaseD.F. Mariniello
  • 17:50–18:00COMISA and comorbiditiesV. D'Agnano
  • 18:00–18:10Allergic rhinitis and asthma: current and novel therapyA. Costigliola
  • 18:10–18:20Expert OpinionR. Cianci, C. Battiloro, A. Costigliola
  • 18:20–18:30Closing remarksA. Bianco

Responsabili del corso

EUBEA SRL

Provider

ID Provider: N° 360

Città: Napoli (NA)

Tipologia: Società, Agenzie Ed Enti Privati

Stato accreditamento: Standard - 1° Rinnovo

  • Medico chirurgo Andrea Bianco

    Responsabile scientifico

    Specializzazione: Malattie dell'apparato respiratorio

    Struttura: Università della Campania Luigi Vanvitelli, Napoli

    Ruolo: Professore Ordinario, Dipartimento di Scienze Mediche Traslazionali

Relatori e docenti

  • Medico chirurgo Lucia Altucci

    Relatore

    Specializzazione: Oncologia

    Struttura: Università degli Studi della Campania L. Vanvitelli

    Ruolo: Professore Ordinario di Patologia Generale

  • Medico chirurgo Luigi Aronne

    Relatore

    Specializzazione: Malattie dell'apparato respiratorio

    Struttura: UOC Clinica Pneumologica L. Vanvitelli, Napoli

    Ruolo: Dirigente medico I livello

  • Biologo Maria Luisa Balestrieri

    Moderatore

    Struttura: Università Vanvitelli di Napoli

    Ruolo: Professore Ordinario di Biochimica

  • Medico chirurgo Ciro Battiloro

    Relatore

    Specializzazione: Malattie dell'apparato respiratorio

    Struttura: A.O.R.N. dei Colli-Monaldi, Napoli

    Ruolo: Dirigente Medico, U.O.C. Pneumologia ad indirizzo Oncologico

  • Medico chirurgo Roberto Bianco

    Moderatore

    Specializzazione: Oncologia

    Struttura: Università Federico II di Napoli

    Ruolo: Professore Ordinario di Oncologia Medica

Domande frequenti

L'evento è accreditato per: Medico Chirurgo (Allergologia Ed Immunologia Clinica, Geriatria, Oncologia, Pediatria, Otorinolaringoiatria, Malattie Dell'apparato Respiratorio, Neurologia, Chirurgia Toracica, Cardiologia, Medicina Interna, Chirurgia Generale, Anestesia E Rianimazione, Medicina Generale (Medici Di Famiglia)).

Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.

Sei un provider ECM?

Contattaci per scoprire come possiamo collaborare.

Contattaci